This page brings together the Agency's latest information on diseases causing problems with the brain and nervous system, including Alzheimer's disease, Parkinson's disease and multiple sclerosis. It lists:
- the ten newest and recently updated medicines authorised for the treatment of neurodegenerative diseases in the European Union (EU);
- the most recent opinions on medicines for neurodegenerative diseases that are pending authorisation by the European Commission (EC);
- the latest news and press releases related to neurodegenerative diseases;
- the Agency's events on topics related to neurodegenerative diseases.